Ani, A.; Lupisella, S.; Sirolli, V.; Bucci, S.; Amoroso, L.; Pavone, B.; Pieroni, L.; Sacchetta, P.; Bonomini, M. Proteomic evaluation of protein adsorption capacity of various haemodialysis membranes. Mol. Biosyst. 2012, eight, 1029?039. 30. Vanholder, R.; de Smet, R.; Glorieux, G.; Argil?A.; Baurmeister, U.; Brunet, P.; Clark, W.; s, Cohen, G.; de Deyn, P.P.; Deppisch, R.; et al. Critique on uremic toxins: Classification, concentration and interindividual variability. Kidney Int. 2003, 63, 1934?943. 31. Duranton, F.; Cohen, G.; de Smet, R.; Rodriguez, M.; Jankowski, J.; Vanholder, R.; Argil?A. s, Typical and pathologic concentrations of uremic toxins. J. Am. Soc. Nephrol. 2012, 23, 1258?270.Toxins 2014,32. Nishio, T.; Takamura, N.; Nishii, R.; Tokunaga, J.; Yoshimoto, M.; Kawai, K. Influences of haemodialysis around the binding sites of human serum albumin: Possibility of an efficacious administration strategy applying binding inhibition. Nephrol. Dial. Transplant. 2008, 23, 2304?310. 33. Watanabe, H.; Noguchi, T.; Miyamoto, Y.; Kadowaki, D.; Kotani, S.; Nakajima, M.; Miyamura, S.; Ishima, Y.; Otagiri, M.; Maruyama, T. Interaction in between two sulfate-conjugated uremic toxins, p-cresyl sulfate and indoxyl sulfate, in the course of binding with human serum albumin. Drug Metab. Dispos. 2012, 40, 1423?428. 34. Van der Vusse, G.J. Albumin as fatty acid transporter. Drug Metab. Pharmacokinet. 2009, 24, 300?07. 35. Banerjee, T.; Singh, S.K.; Kishore, N.8-Bromo-5-chloroquinoline Purity Binding of naproxen and amitriptyline to bovine serum albumin: Biophysical elements.Formula of 2647503-30-6 J. Phys. Chem. B 2006, 110, 24147?4156. 36. Olsen, H.; Andersen, A.; Nordbo, A.; Kongsgaard, U.E.; Bormer, O.P. Pharmaceutical-grade albumin: Impaired drug-binding capacity in vitro. BMC Clin. Pharmacol. 2004, four, doi:ten.1186/1472-6904-4-4. 37. De Smet, R.; van Kaer, J.; van Vlem, B.; de Cubber, A.; Brunet, P.; Lameire, N.; Vanholder, R. Toxicity of totally free p-cresol: A prospective and cross-sectional evaluation. Clin. Chem. 2003, 49, 470?78. 38. Weisiger, R.A.; Ostrow, J.D.; Koehler, R.K.; Webster, C.C.; Mukerjee, P.; Pascolo, L.; Tiribelli, C. Affinity of human serum albumin for bilirubin varies with albumin concentration and buffer composition.PMID:25027343 J. Biol. Chem. 2001, 276, 29953?9960. 39. Berg?-Lefranc, D.; Chaspoul, F.; Calaf, R.; Charpiot, P.; Brunet, P.; Gallice, P. Binding of p-cresylsulfate and p-cresol to human serum albumin studied by microcalorimetry. J. Phys. Chem. B 2010, 114, 1661?665. 40. Schwinn, D.A.; Schafer, S.L. Anesthesia; Miller, R.D., Ed.; Churchill Livingstone: London, UK, 2000; pp. 15?8. 41. Meijers, B.K.I.; Bammens, B.; de Moor, B.; Verbeke, K.; Vanrenterghem, Y.; Evenepoel, P. Absolutely free p-cresol is linked with cardiovascular illness in hemodialysis sufferers. Kidney Int. 2008, 73, 1174?180. 42. De Smet, R.; van Kaer, J.; Liebich, H.; Lesaffer, G.; Verstraete, A.; Dhondt, A.; Duym, P.; Lameire, N.; Vanholder, R. Heparin-induced release of protein-bound solutes throughout hemodialysis is definitely an in vitro artifact. Clin. Chem. 2001, 47, 901?09. ?2014 by the authors; licensee MDPI, Basel, Switzerland. This article is definitely an open access report distributed under the terms and situations in the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).
Ischemia-reperfusion (IR) injury is caused by transient disruption of blood provide in tissues followed by reperfusion. This phenomenon contributes to several clinical troubles following stroke, myocardial infarction, shock, and organ transplantation. Emerging evidence sugge.
